Background/Aims: Advanced glycation end products (AGEs) could elicit oxidative stress, trigger and aggravate endothelium damage in several ischemic retinopathies including diabetic retinopathy (DR). The leaves of Eucommia ulmoides O., also referred to as Tu-chung or Du-zhong, have been used for the treatment of hypertension and diabetes, showing great antioxidant activity and anti-glycation activity. Lignans is one of the main bioactive components of Eucommia ulmoides. This study mainly investigated the effect of lignans treatment on AGEs-induced endothelium damage. Methods: MTT assay, Hoechst staining, and calcein-AM/ propidium iodide (PI) staining was conducted to determine the effect of lignans treatment on endothelial cell function in vitro. Retinal trypsin digestion, Evans blue assay, isolectin staining, and western blots were conducted to determine the effect of lignans treatment on retinal microvascular function in vivo. Western blot, protein immunoprecipitation (IP), MTT assays, and enzyme activity assay was conducted to detect the effect of ligans treatment on oxidative stress response. Results: Lignans protected retinal endothelial cell against AGEs-induced injury in vitro and diabetes-induced vascular dysfunction in vivo. Lignans treatment could regulate oxidative stress response in retinal endothelial cell line, retina, and liver. Moreover, we showed that NRF2/HO-1 signaling was critical for lignans-mediated oxidative stress regulation. Conclusion: Lignans treatment could protect against endothelial dysfunction in vivo and in vitro via regulating Nrf2/HO-1 signaling. Lignans might be developed as a promising drug for the treatment of diabetes-induced microvascular dysfunction.
Introduction
Several ischemic retinopathies such as diabetic retinopathy and retinopathy of prematurity are believed to be associated with endothelial cell injury [1, 2] . A series of pathological factors, such as inflammation, oxidative stress, Ca 2+ overload, are found to be associated with endothelial dysfunction, which could lead to the onset and development of vascular complications [3] [4] [5] [6] [7] . Advanced glycation end products (AGEs) are proteins or lipids that become glycated after exposure to high glucose [8, 9] . They cause cellular dysfunction by activate AGEs receptor (RAGE). AGE-RAGE signaling could elicit oxidative stress and inflammation, trigger and aggravate endothelium damage [10] . Thus, increasing attentions have been paid to develop strategies that protect against AGEs-induced endothelial cell injury. Eucommia ulmoides Oliv., also called Du-zhong, is an old tonic herb in the traditional Chinese medicine. It has been reported to elicit pharmacological effects on coronary blood flow, pain relief, diuresis, blood pressure and lipid metabolism [11] [12] [13] [14] . Eucommia ulmoides extract could exhibit anti-oxidant [15] , anti-hypertensive [16] , anti-hyperlipidemic [17] , anti-hyperglycemic [11] , and anti-obesity effects [18] . The water extract from Du-zhong leaves has recently been reported to possess anti-oxidant effect and prevent oxidative stress damage and lipid-peroxidation induced by the reaction of Fe
3+
-EDTA/H 2 O 2 and ascorbic acid [12, [19] [20] [21] . However, the protective effect of Du-zhong on AGEs-induced endothelial dysfunction and the underlying mechanism has not been elucidated.
Previous studies have reported that 112 bioactive components have been isolated from Eucommia ulmoides, including 28 lignans, 24 iridoids, 27 phenolics, 6 steroids, 5 terpenoids, 13 flavonoids and 9 other compounds. Some of these compounds have great potential for treating human diseases. Lignans is a class of secondary metabolites consisting of two phenyl-propanoid molecules connected by 8-8' carbon atoms. Lignans and their derivatives are the key components of Eucommia ulmoides [22] [23] [24] . In this study, we investigated the effect of lignans treatment on AGEs-induced endothelial dysfunction in vivo and in vitro. Our finding revealed that lignans was a potential candidate to prevent vascular injury in ischemic retinopathies.
Materials and Methods

Preparation of lignans extract from Du-zhong (Eucommia ulmoides Oliv.)
Fresh Du-zhong leaves were collected in October 2014 (Temperature: 32±2.5°C) at Chengdu, Sichuan Province, People's Republic of China. The leaves were briefly treated with steam at 100-110°C immediately after collection. 100 g powder was refluxed with 50% alcohol for 3 h. The extract was concentrated, and then subjected to AB-8 macroporous adsorptive resins eluted using distilled water, 10% alcohol, 30% alcohol, and 50% alcohol (V/V). The 50% fraction was concentrated and subjected to the silica gel, and then eluted by distilled water, 20% alcohol, 40% alcohol, and 60% alcohol (V/V). It was then evaporated to dryness under reduced pressure for the total elimination of alcohol, followed by lyophilization, yielding dry residue.
Preparation and characterization of AGEs
AGEs-BSA (AGEs) was produced using D-glucose and fatty acid-free BSA. In brief, 1 g of BSA (40 mg/ mL) was incubated with 2.2 g of D-glucose in 25 mL of PBS (pH 7.4) at 37 °C for 90 days in dark. They were dialyzed in PBS (pH 7.4) for 96 h to remove the free glucose, and passed over Detoxigel columns (Thermo Fisher) to remove endotoxin. The group using BSA prepared by the same incubation without D-glucose was taken as the control. The protein concentration was determined by BCA assay and adjusted to 1 mg/mL.
Induction of diabetic mice and injection
Three-month-old male C57BL/6 mice were housed in the light/dark (12 h/12 h) controlled room at a controlled ambient temperature of 23±1.0 0 C with 50%±5% relative humidity. Diabetes was induced by the injection of streptozocin (STZ, 70 mg/kg B.W.) freshly dissolved in a 0.1 M citrate buffer (pH 4.3). The control group was only injected with the citrate buffer. Hyperglycemia was detected 48 h after injection based on blood glucose level ≥16.7 mmol/L. Intravitreal injection of lignans was performed using a 33-gauge needle (Hamilton, Reno, NV, USA) into the vitreous body of the eye.
Measurement of blood-retinal barrier breakdown using Evans blue
Blood-retinal barrier breakdown was determined using Evans blue leakage from retinal blood vessels [25] [26] [27] . In brief, the right jugular vein and right iliac artery were cannulated, and filled with heparinized saline. Evans blue was injected through the jugular vein (50 mg/kg). 0.1 ml blood was drawn from the iliac artery to obtain plasma Evans blue concentration. After dye was circulated for 1 h, the chest cavity was opened. Evans blue amount in the retina was quantified by spectrofluorophotometry. The concentration of Evans blue was obtained from the standard curve and normalized to the dry weight of retina.
Retinal trypsin digestion
Retinal trypsin digestion was performed according to the protocols with minor modifications [28] . The enucleated eyes were fixed in 10% neutral buffered formalin, and then incubated with 3% trypsin until the medium became cloudy. The retinas were shaken to free vascular network from adherent retinal tissue, washed in fresh water, and mounted on glass slides for dry. Finally, the retinas were stained with PAS/ hematoxylin to visualize retinal vasculature.
Cells culture RF/6A cells were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). They were cultured in RPMI1640 medium supplemented with 10% fetal bovine serum. Medium was replaced every 2 days. Cells were used for experiment until they reached 80-90% confluence.
Cell viability
Cell viability was determined using MTT assay [29] . Briefly, RF/6A cells (5×10 4 cells/well) were seeded into the 96-well plates and left to adhere overnight. After specific treatment, 10 μl MTT (5 mg/ml) was added and incubated in dark for 3 h at 37°C. After the supernatants were discarded, 100 mM DMSO solution was added to dissolve formazan crystals. The absorbance was determined at 570 nm wavelength.
ROS assay
Reactive oxygen species (ROS) level was determined using ROS assay kit (Sigma) according to the manufacture's protocol. Briefly, RF/6A cells were incubated with 2, 7-dichlorofluoresceindiacetate (DCFH-DA) at 37°C for 3 h and washed three times by PBS buffer. The fluorescence of 2, 7-dichlorofluorescein (DCF) was detected using a microplate reader (Molecular Devices).
Western blot
The retinas or cells were lysed in the ice-cold RIPA buffer [50 mM Tris HCl (pH 7.4), 250 mM NaCl, and 1% Nonidet P-40, with a protease inhibitor cocktail]. The protein sample (50 μg) was separated by sodium dodecyl sulfate poly acrylamide gel electrophoresis (SDS-PAGE, 10%), and then transferred onto nitrocellulose membranes. The blot was blocked with 5% BSA and then incubated with the primary antibody at 4°C overnight. After rinsing, the membranes were incubated with horseradish-conjugated secondary antibody, reacted with enhanced chemiluminescence reagents (Pierce).
Calcein-AM /PI staining
Cell apoptosis was detected by calcein-AM/PI staining [30] [31] [32] . In brief, RF/6A cells were fixed with 70% ethanol for 15 min. After the corresponding treatments, they were stained with calcein-AM solution (10 µmol/l) for 15 min. After washing with PBS buffer, these cells were stained with PI (10 µmol/l) for additional 15 min. The live cells were observed using a 490 nm excitation filter, whereas the dead cells were observed using a 545 nm excitation filter.
Hoechst staining
Hoechst staining was performed according to previously reported studies [33, 34] . RF/6A cells were fixed in 4% formaldehyde for 15 min at room temperature. They were then permeabilized with Triton-X 100 for additional 15 min. After washing with PBS buffer, these cells were incubated with Hoechst 33342 (100 μg/ml) for 5 min. The stained nuclei were observed by a fluorescent microscope.
Result
Lignans protects retinal endothelial cell against AGEs-induced injury in vitro
We first examined the cytotoxic effect of AGEs on RF/6A cell function. The result showed that AGEs at the concentration of 50 μg/ml resulted in approximately 50% loss of cell viability (Fig. 1A) . This concentration was chosen for the following experiments. Moreover, we found that lignans at the tested concentrations was safe for RF/6A cells (Fig. 1B) . Notably, lignans could prevent RF/6A cells from AGEs-induced endothelial cell viability reduction (Fig. 1C) . We further employed Hoechst staining (Fig. 1D) and PI/Calcein-AM staining (Fig.   Fig. 1 . Lignans protects retinal endothelial cell against AGEs-induced injury in vitro. (A) RF/6A cells were treated with different concentrations of AGEs (25, 50, 100, and 150 μg/ml) or left untreated for 48 h (Ctrl, 0 μg/ ml) (n=4; *P=0.024, 0.019, 0.015, 0.008, respectively). (B) RF/6A cells were treated with different concentrations of lignans (25, 50, 75 , and 100 μg/ml) or left untreated for 48 h (Ctrl, 0 μg/ml) (n=4). (C) RF/6A cells were pretreated with or without lignans (50 μg/ ml) or PBS for 6 h, and then exposed to AGEs (50 μg/ mL) or left untreated for 48 h (Ctrl, 0 μg/ml) (n=4; *P=0.021, 0.042, 0.023, respectively; # P=0.028, 0.025, respectively). Cell viability was detected using MTT method. The data was shown as the relative change compared with the Ctrl group. (D) RF/6A cells were treated as shown in Fig. 1C . Apoptotic cells were analyzed using Hoechst staining and quantitated. The data was shown as means±SEM, and represented four individual experiments in which >200 cells were counted. Arrowheads: apoptotic nuclei; Scale bar: 20 μm (n=4; *P=0.007, 0.015, 0.011, respectively; # P=0.016, 0.019, respectively). (E) RF/6A cells were treated as shown in Fig. 1C . Cell apoptosis was determined by calcein-AM/PI staining. n=4, Scale bar: 50 μm. "*" indicated significant difference compared with the Ctrl group. "
# " indicated significant difference between the marked groups. NS indicted no significant difference. All data was from three independent experiments. *P<0.05, **P <0.01, # P<0.05.
ameliorate visual function and partially reverse the decreased trend of a-wave, b-wave, and oscillatory potentials (Fig. 2E) . Taken together, these results suggest that lignans protects against diabetes-induced retinal vascular dysfunction in vivo.
Effect of lignans treatment on AGEs-induced oxidative stress in vivo and in vitro
Many studies have reported that the interaction between AGEs and their receptor RAGE elicits oxidative stress and then leads to cascade signaling, such as inflammation and apoptosis responses [10, 38] . We thus examined the effect of lignans treatment on AGEsinduced oxidative stress. Lignans treatment could decrease AGEs-induced ROS production in RF/6A cells and diabetic retinas (Fig. 3A and 3B ). The degree of oxidative stress is regulated by many enzymes, including catalase, glutathione peroxidase, and superoxide dismutase [39] . The result showed that lignans treatment could significantly up-regulated the activity of oxidative stress-related enzymes in both retina and liver tissues in the diabetic animals ( Table 1) .
Lignans protects against AGEs-induced cell injury via regulating oxidative stress-related protein expression NRF2 and its dependent gene HO-1 are important proteins involved in regulating oxidative stress [40] . Lignans treatment significantly increased the levels of NRF2 and HO-1 protein expression (Fig. 4A) . Normally, NRF2 interacts with Kelch-like ECH-associated protein 1 (KEAP1) and is thereby targeted for proteasomal degradation. Oxidative stress could oxidize redox-sensitive cysteine residues on KEAP1, resulting in the dissociation of KEAP1 from NRF2 [41] . Protein-IP experiments showed that lignans treatment could disrupt NRF2/Keap1 association in cytosol (Fig. 4B) . We also found the phenomenon that NRF2 protein accumulation and nuclear translocation (Fig. 4C) . In addition, MTT assay and cell morphology observation showed that HO-1 inhibitor, ZnPP, almost reversed the beneficial role of lignans against oxidative stress (Fig. 4D and 4E) . Thus, lignans could activate NRF2/ HO-1 signaling to combat against oxidative stress.
Discussion
AGEs are proteins or lipids that become glycated after exposure to sugars. They are prevalent in diabetic vasculature and contribute to the development of vascular dysfunction [8] . AGEs have been reported to elicit a wide range of cell responses that contribute to diabetic complications, vascular and renal disease and Alzheimer's disease [42] [43] [44] . Thus, preventing AGEs-induced endothelial dysfunction could reduce or hinder diabetes-induced vascular injury. Here we revealed that lignans, the main bioactive components of Eucommia ulmoides, was a potential candidate to prevent AGEs-induced endothelial dysfunction in vivo and in vitro.
Diabetic retinopathy is an important microvascular complication of diabetes mellitus. It is usually accompanied by inflammation, neovascularization, vascular hyperpermeability, and vascular cell dysfunction [45] . Lignans treatment could alleviate diabetic-induced retinal neovascularization, vascular leakage, and inflammation in vivo. Under diabetic condition, an unceasing and excessive proliferation of endothelial cells occurs in retinal vascular system [46] . Thus, any factors altering endothelial cell function could lead to retinal microvascular dysfunction. Lignans treatment could significantly regulate endothelial cell viability and high glucose-induced cell apoptosis in vitro. Thus, it is not surprised that lignans is a promising drug for the treatment of microvascular dysfunction.
Oxidative stress plays an important role in the development of diabetes-related vascular complications. The metabolic abnormalities of diabetes cause mitochondrial superoxide overproduction in endothelial cells [47] . Increased superoxide production could lead to increased formation of AGEs and increased expression of the receptor for AGEs and its activating ligands [38, 48] . Lignans treatment could decrease ROS production in RF/6A cells and diabetic retinas. Moreover, lignans treatment could significantly up-regulated the activity of oxidative stress-related enzymes. Decreased superoxide production would lead to decreased formation of AGEs, which could decrease AGEs-induced endothelial dysfunction in vivo and in vitro.
NRF2 is an important transactivator of several protective and metabolic enzymes, such as γ-glutamylcysteine ligase, glutathione reductase (GSHRd), aldo-keto reductase (AKRd), glutathione transferases, quinone reductase (NQO1), HO-1 [49, 50] . NRF2-linked gene expression plays a critical role in the protection of cells against oxidative stress. Lignans treatment could lead to the activation of Nrf2/ARE signaling. Inhibition of NRF2/ HO-1 signaling could decrease the protective effect of lignans on AGEs-induced endothelial dysfunction.
In conclusion, we demonstrated that lignans treatment could protect against on AGEsinduced endothelial dysfunction in vivo and in vitro via regulating Nrf2/HO-1 signaling. This study provides significant experimental data for developing lignans as a therapeutic agent for the prevention and treatment of diabetes-related vascular complication.
